Sareum Holdings competitorsClear all

Sareum Holdings's top competitors include Xilio Therapeutics and RAPT Therapeutics.
Sareum Holdings
Sareum Holdings
Sareum Holdings discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases.
Xilio Therapeutics
Xilio Therapeutics
Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
Founding Date
Founding Date
2003
Founding Date
2015
Founding Date
2015
Type
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Pampisford, GB HQ
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
6
Employees
655% increase
Employees
64
Valuation ($)
Valuation ($)
154 m
Valuation ($)
N/A
Valuation ($)
671.5 m
Twitter followers
Twitter followers
1.3 k
Twitter followers
103
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
370405
Alexa Website Rank
N/A
Alexa Website Rank
324199

Financial

Revenue (est.)
Revenue (est.)
£2.5m (FY, 2007)
Revenue (est.)
N/A
Revenue (est.)
$5m (FY, 2020)
Net income
Net income
(£527.4k) (FY, 2007)
Net income
N/A
Net income
($52.9m) (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 37.5m
Total funding raised
$ 176m
For sources of this data, please see the company profile

View company profiles

Xilio Therapeutics
HQ
Cambridge, US
Employees
65↑ 5% increase

Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.

View company
RAPT Therapeutics
HQ
South San Francisco, US
Employees
64

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.

View company